Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

NCT06193759 is registered in ClinicalTrials.gov with Children's National Research Institute as lead sponsor.

NCT NCT06193759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Lead sponsor
Children's National Research Institute
Phase
Phase 1
Overall status
Recruiting
Start date
September 20, 2024
Completion date
December 29, 2032
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical teratoid/rhabdoid tumor of cns, embryonal brain tumor not otherwise specified, embryonal tumor with multilayered rosettes, medulloblastoma, childhood, pineoblastoma, recurrent ependymoma